Insulin aspart protamine and insulin aspart
- Biologic
- Insulin Aspart Protamine and Insulin Aspart Mix 70/30
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Insulin aspart protamine and insulin aspart: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store unused Insulin Aspart Protamine and Insulin Aspart in a refrigerator between 2°C to 8°C (36°F to 46°F).
- Freezing
- Do not freeze
Label statement
Do not freeze Insulin Aspart Protamine and Insulin Aspart or use Insulin Aspart Protamine and Insulin Aspart if it has been frozen.
- Room temperature
- up to 28 days at or below 30°C (86°F)
Label statement
The storage conditions are summarized in the following table: Table 7: Storage conditions for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 vial and FlexPen Not in-use (unopened) Room Temperature (up to 30°C [86°F]) Not in-use (unopened) Refrigerated (2°C to 8°C [36°F to 46°F]) In-use (opened) Room Temperature (up to 30°C [86°F]) 10 mL multiple-dose vial 28 days Until expiration date 28 days (refrigerated/room temperature) 3 mL single-patient-use FlexPen 14 days Until expiration date 14 days (Do not refrigerate)
- Room temperature
- up to 28 days
Label statement
Unopened vials should be thrown away after 28 days, if they are stored at room temperature.
- Room temperature
- up to 28 days at or below 30°C (86°F)
Label statement
Opened Insulin Aspart Protamine and Insulin Aspart Mix 70/30 vials can be stored in the refrigerator 36 ° F to 46 ° F (2 ° C to 8 ° C) or at room temperature below 86 ° F (30 ° C) for up to 28 days. .
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (13)
- Store unused Insulin Aspart Protamine and Insulin Aspart in a refrigerator between 2°C to 8°C (36°F to 46°F).
- Do not freeze Insulin Aspart Protamine and Insulin Aspart or use Insulin Aspart Protamine and Insulin Aspart if it has been frozen.
- Do not expose Insulin Aspart Protamine and Insulin Aspart to excessive heat or light.
- Always remove the needle after each injection and store Insulin Aspart Protamine and Insulin Aspart FlexPen without a needle attached.
- The storage conditions are summarized in the following table: Table 7: Storage conditions for Insulin Aspart Protamine and Insulin Aspart Mix 70/30 vial and FlexPen Not in-use (unopened) Room Temperature (up to 30°C [86°F]) Not in-use (unopened) Refrigerated (2°C to 8°C [36°F to 46°F]) In-use (opened) Room Temperature (up to 30°C [86°F]) 10 mL multiple-dose vial 28 days Until expiration date 28 days (refrigerated/room temperature) 3 mL single-patient-use FlexPen 14 days Until expiration date 14 days (Do not refrigerate)
- How should I store Insulin Aspart Protamine and Insulin Aspart Mix 70/30? .
- Do not freeze Insulin Aspart Protamine and Insulin Aspart Mix 70/30.
- Do not use Insulin Aspart Protamine and Insulin Aspart Mix 70/30 if it has been frozen. .
- Keep Insulin Aspart Protamine and Insulin Aspart Mix 70/30 away from heat or light.
- Store unopened Insulin Aspart Protamine and Insulin Aspart Mix 70/30 vials in the refrigerator at 36 ° F to 46 ° F (2 ° C to 8 ° C). .
- Unopened vials may be used until the expiration date printed on the label, if they have been stored in the refrigerator. .
- Unopened vials should be thrown away after 28 days, if they are stored at room temperature.
- Opened Insulin Aspart Protamine and Insulin Aspart Mix 70/30 vials can be stored in the refrigerator 36 ° F to 46 ° F (2 ° C to 8 ° C) or at room temperature below 86 ° F (30 ° C) for up to 28 days. .
FDA label version 8, effective February 28, 2023. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.